ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Ferring
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
Introducing Menogon 75IU Injection, a powerful solution commonly known as hMG or Menotropin, specifically designed to combat infertility in women. This hormone-rich medication effectively stimulates ovarian egg production, especially beneficial for those facing ovarian failure. Sourced from the urine of postmenopausal women, Menogon boasts elevated levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and other essential gonadotropins. Administered via intramuscular injection, it offers a targeted approach to fertility enhancement.
While Menogon 75IU Injection is a vital tool for many, potential side effects may include headaches, mood fluctuations, fatigue, weight gain, localized swelling, breast tenderness, and enlargement. A noteworthy concern is abdominal pain due to ovarian hyperstimulation syndrome (OHSS), which can arise from excessive egg production. Additionally, there?s a possibility of conceiving twins following treatment. Before starting Menogon, it?s essential to consult your doctor regarding any of the following medical conditions:
- Allergies to menotropins or gonadotropins
- Vaginal bleeding
- Ovarian cysts
Dosage is personalized to meet individual needs, ensuring optimal effectiveness. For the best chances of conception, it is recommended to time intercourse within 12 to 36 hours after receiving the Menogon 75IU Injection. If the first treatment cycle does not yield results, it?s important to reassess the situation. Should ovulation not occur after three treatment cycles, please consult your doctor to discuss your options regarding Menogon 75IU Injection.